Trends in the use of cytoreductive nephrectomy in the United States.
about
Percutaneous biopsy for risk stratification of renal massesRacial disparities in renal cell carcinoma: a single-payer healthcare experienceComprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy.Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival.A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma.
P2860
Trends in the use of cytoreductive nephrectomy in the United States.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Trends in the use of cytoreductive nephrectomy in the United States.
@ast
Trends in the use of cytoreductive nephrectomy in the United States.
@en
type
label
Trends in the use of cytoreductive nephrectomy in the United States.
@ast
Trends in the use of cytoreductive nephrectomy in the United States.
@en
prefLabel
Trends in the use of cytoreductive nephrectomy in the United States.
@ast
Trends in the use of cytoreductive nephrectomy in the United States.
@en
P2093
P2860
P50
P1476
Trends in the use of cytoreductive nephrectomy in the United States.
@en
P2093
Benjamin A Gartrell
Che-Kai Tsao
Erin L Moshier
Guru Sonpavde
James H Godbold
Matthew D Galsky
Michael A Palese
Simon J Hall
P2860
P304
P356
10.1016/J.CLGC.2012.03.008
P407
P577
2012-05-30T00:00:00Z